Catalyst Wire Dossier Catalyst Wire Dossier

Riociguat (Adempas)

riociguat · Bayer
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Riociguat (Adempas), covering 2019-02-21 to 2025-04-30. Get the full timeline:

Most recent: Clinical Trial Update: Riociguat-Discontinue Effects on Right HEART in CTEPH (RED-HEART) [Phase 3]

See pricing